Patient B.Y., a 60-year-old man, has had hypertension and diabetes for 30 years. His vision was weak, and he could not read. His blood pressure (BP) had been poorly controlled for 30 years, usually ranging from 150/100 to 170/110. When he visited the Infra Life clinic, his BP remained at 160–170/110 despite taking maximum doses of prazosin, nifedipine, and enalapril. His diastolic pressure had never been below 90 mmHg in the last 20 years. He also took high doses of glibenclamide and metformin for diabetes.
He underwent a course of resonance IR therapy using GI, ZB, KL, and AK emitters.
Result: His BP significantly decreased and stabilized at 130/70. Prazosin was discontinued, and the doses of the other two antihypertensive drugs were halved. His BP remained stable at 130/80 in the morning, sometimes reaching 120–130/70.
His vision improved remarkably—he could read the Quran and newspapers. Peripheral neuropathy in his toes improved by 90% compared to the initial state. He lost 9 kg through diet. His physical condition improved, and he could walk for half an hour without fatigue.
No side effects were observed. The improvement in physical condition and weight loss were considered positive side effects, commonly seen in most patients.
Comments:
The ZB emitter can be used to treat diabetic retinopathy. Since it is effective for treating diabetic retinopathy, it may also be recommended for prevention. The therapy is simple—just 1 minute, two to three times a day, or possibly once daily for prevention. In 35 out of 40 patients, BP stabilization was observed. Dose reduction or discontinuation of medications was also an interesting phenomenon. However, the question of how to maintain BP using IR emitters remains under study.
He underwent a course of resonance IR therapy using GI, ZB, KL, and AK emitters.
Result: His BP significantly decreased and stabilized at 130/70. Prazosin was discontinued, and the doses of the other two antihypertensive drugs were halved. His BP remained stable at 130/80 in the morning, sometimes reaching 120–130/70.
His vision improved remarkably—he could read the Quran and newspapers. Peripheral neuropathy in his toes improved by 90% compared to the initial state. He lost 9 kg through diet. His physical condition improved, and he could walk for half an hour without fatigue.
No side effects were observed. The improvement in physical condition and weight loss were considered positive side effects, commonly seen in most patients.
Comments:
The ZB emitter can be used to treat diabetic retinopathy. Since it is effective for treating diabetic retinopathy, it may also be recommended for prevention. The therapy is simple—just 1 minute, two to three times a day, or possibly once daily for prevention. In 35 out of 40 patients, BP stabilization was observed. Dose reduction or discontinuation of medications was also an interesting phenomenon. However, the question of how to maintain BP using IR emitters remains under study.